Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 116 entries
View as:

Very Small Embryonic-like Stem Cells for Facial Skin Antiaging

Phase: N/A Priority: Normal
NCT ID: NCT03976206 Org: User:
Start: 07/06/19 End: 07/01/20 Due: 07/01/21

Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT02430662 Org: User:
Start: 01/01/15 End: 03/01/21 Due: 03/01/22

Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02843581 Org: User:
Start: 07/01/16 End: 07/01/19 Due: 07/01/20

Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT02335112 Org: User:
Start: 01/01/15 End: 01/01/21 Due: 01/01/22

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03540199 Org: User:
Start: 04/10/18 End: 09/10/20 Due: 09/10/21

Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02849314 Org: User:
Start: 07/01/16 End: 07/01/19 Due: 07/01/20

Bioinformation Therapy for Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03239171 Org: User:
Start: 09/02/17 End: 09/02/18 Due: 09/02/19

Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02343835 Org: User:
Start: 01/01/15 End: 05/01/21 Due: 05/01/22

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03509298 Org: User:
Start: 04/12/18 End: 07/12/20 Due: 07/12/21

Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient

Phase: N/A Priority: Normal
NCT ID: NCT02338778 Org: User:
Start: 01/31/15 End: 08/31/15 Due: 08/31/16

Irreversible Electroporation(IRE) For Unresectable Renal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02335827 Org: User:
Start: 01/01/15 End: 01/01/21 Due: 01/01/22

Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02718859 Org: User:
Start: 03/01/16 End: 03/01/19 Due: 03/01/20

CAR-T Cell Immunotherapy for HCC Targeting GPC3

Phase: N/A Priority: Normal
NCT ID: NCT02723942 Org: User:
Start: 06/30/15 End: 08/15/16 Due: 08/15/17

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03501056 Org: User:
Start: 03/27/18 End: 07/27/20 Due: 07/27/21

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02523417 Org: User:
Start: 05/31/15 End: 02/29/16 Due: 02/28/17

Irreversible Electroporation(IRE) For Unresectable Hilus Pulmonis Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT02430597 Org: User:
Start: 01/01/15 End: 03/01/21 Due: 03/01/22

Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient

Phase: N/A Priority: Normal
NCT ID: NCT02338752 Org: User:
Start: 01/31/15 End: 08/31/15 Due: 08/31/16

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Cervical Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02523365 Org: User:
Start: 05/31/15 End: 08/31/16 Due: 08/31/17

Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02074046 Org: User:
Start: 02/28/14 End: 03/31/15 Due: 03/31/16

The Detection of CTCs in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment.

Phase: N/A Priority: Normal
NCT ID: NCT02406846 Org: User:
Start: 06/30/13 End: 12/31/15 Due: 12/31/16

Comparison of Autogenic and Allogenic NK Immunotherapy on the Outcome of Recurrent Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02853903 Org: User:
Start: 07/01/16 End: 07/01/19 Due: 07/01/20

Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02843802 Org: User:
Start: 07/01/16 End: 07/01/19 Due: 07/01/20

Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT02430753 Org: User:
Start: 01/01/15 End: 02/01/21 Due: 02/01/22

Combination of Cryosurgery and NK Immunotherapy for Recurrent Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT02849366 Org: User:
Start: 07/01/16 End: 07/01/19 Due: 07/01/20

Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT02430701 Org: User:
Start: 01/01/15 End: 04/01/21 Due: 04/01/22